Alexion to Highlight Rare Disease Portfolio at Investor Day

Category:

Dateline:

Public Company Information:

NASDAQ:

ALXN

BOSTON--(BUSINESS WIRE)--Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that the Company
will host an Investor Day on Wednesday, March 20, from 8:00am to 12:30pm
ET. Alexion’s leadership team will highlight the continued advancement
of the Company’s highly innovative pipeline which is focused on serving
patients with rare diseases. The Company will also provide updates on
the commercial business and key aspects of its long-term growth strategy.

An audio webcast will be available live and you can access the webcast
at: https://ir.alexion.com/.
An archived version of the remarks will also be available through the
Company’s website for a limited time.